133 related articles for article (PubMed ID: 6307772)
1. Ranitidine in the treatment of duodenal and prepyloric ulcer: comparison of two dosage regimens.
Brunner H; Pesendorfer FX; Pötzi R
J Int Med Res; 1983; 11(3):167-72. PubMed ID: 6307772
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ranitidine and high-dose antacid in the treatment of prepyloric or duodenal ulcer. A double-blind controlled trial.
Lauritsen K; Bytzer P; Hansen J; Bekker C; Rask-Madsen J
Scand J Gastroenterol; 1985 Jan; 20(1):123-8. PubMed ID: 3887547
[TBL] [Abstract][Full Text] [Related]
3. Ranitidine in the treatment of gastric, prepyloric and duodenal ulcer--a controlled prospective double-blind trial.
Darle N; Almskog B; Falk A; Fredriksen B; Gamklou R; Ivarsson L; Karlström L
Ann Clin Res; 1984; 16(1):6-9. PubMed ID: 6331270
[TBL] [Abstract][Full Text] [Related]
4. Ranitidine in the treatment of peptic ulcer.
Makalinao AU; Zaño FM
Clin Ther; 1984; 6(2):185-92. PubMed ID: 6322992
[TBL] [Abstract][Full Text] [Related]
5. The treatment of duodenal and gastric ulcer with ranitidine--a controlled, multicentre clinical trial.
Gibinski K; Nowak A; Gabryelewicz A; Szalaj W; Hasik J; Klincewicz H; Pokora J; Radwan P; Kosecki P; Pachlewski J
Dtsch Z Verdau Stoffwechselkr; 1982; 42(2-3):64-9. PubMed ID: 6286274
[TBL] [Abstract][Full Text] [Related]
6. Double blind comparative study of omeprazole and ranitidine in patients with duodenal or gastric ulcer: a multicentre trial. Cooperative study group.
Gut; 1990 Jun; 31(6):653-6. PubMed ID: 2199347
[TBL] [Abstract][Full Text] [Related]
7. Ranitidine in uncomplicated duodenal ulceration. A double-blind endoscopically controlled trial.
Moshal MG; Spitaels JM; Khan F
S Afr Med J; 1981 Sep; 60(10):393-4. PubMed ID: 6269234
[TBL] [Abstract][Full Text] [Related]
8. Multicentre double blind clinical trial on ranitidine for gastroduodenal ulcer.
Gibinski K; Nowak A; Gabryelewicz A; Szalaj W; Hasik J; Klincewicz H; Pokora J; Radwan P; Kosecki P; Pachlewski J
Hepatogastroenterology; 1981 Aug; 28(4):216-7. PubMed ID: 6115807
[TBL] [Abstract][Full Text] [Related]
9. Comparison of twice-daily ranitidine and placebo in the treatment of duodenal ulcer--a multicentre study in the United Kingdom.
Lee FI; Fielding JD; MacKay C; Mitchell K; Mohammed R; Holmes GK; Hine KR; Gibson JA; Lochee-Bayne E; Stone WD; Orchard RT; Calcraft BJ; Rose JA
Hepatogastroenterology; 1982 Jun; 29(3):127-9. PubMed ID: 6125463
[TBL] [Abstract][Full Text] [Related]
10. A comparative trial of ranitidine 300 mg at night with ranitidine 150 mg twice daily in the treatment of duodenal and gastric ulcer.
Farley A; Lévesque D; Paré P; Thomson AB; Sherbaniuk R; Archambault A; Mahoney K
Am J Gastroenterol; 1985 Sep; 80(9):665-8. PubMed ID: 3898818
[TBL] [Abstract][Full Text] [Related]
11. Ranitidine: a pilot study in Japan.
Takemoto T; Okazaki Y; Okita K; Namiki M; Ishikawa M; Oshiba S; Kurokawa K
Scand J Gastroenterol Suppl; 1981 Jun; 69():125-8. PubMed ID: 6119776
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic double-blind controlled trial of ranitidine vs placebo in the short-term treatment of duodenal ulcer.
Dobrilla G; de Pretis G; Felder M; Chilovi F
Hepatogastroenterology; 1981 Feb; 28(1):49-52. PubMed ID: 6111528
[TBL] [Abstract][Full Text] [Related]
13. Omeprazole heals duodenal, but not gastric ulcers more rapidly than ranitidine. Results of two German multicentre trials.
Classen M; Dammann HG; Domschke W; Hüttemann W; Londong W; Rehner M; Simon B; Witzel L; Berger J
Hepatogastroenterology; 1985 Oct; 32(5):243-5. PubMed ID: 3908262
[TBL] [Abstract][Full Text] [Related]
14. Ranitidine compared with cimetidine in the short-term healing of duodenal ulcer.
Lee FI; Fielding JD; Costello FT
Postgrad Med J; 1983 Feb; 59(688):88-92. PubMed ID: 6302650
[TBL] [Abstract][Full Text] [Related]
15. [Multi-center double-blind clinical trial of ranitidine in the treatment of stomach and duodenal ulcers].
Gibiński K; Nowak A; Gabrylewicz A; Laszewicz W; Hasik J; Klincewicz H; Pokora J; Czarnecki J; Kosecki J; Pachlewski J
Pol Arch Med Wewn; 1982; 68(3):117-24. PubMed ID: 6133269
[No Abstract] [Full Text] [Related]
16. [Side effects and safety of the new histamine H2 receptor antagonist ranitidine in the long-term treatment of patients with stomach and duodenal ulcers].
Meryn S; Pötzi R; Brunner H; Pesendorfer FX; Pamperl H
Wien Klin Wochenschr; 1983 Apr; 95(9):310-2. PubMed ID: 6137111
[TBL] [Abstract][Full Text] [Related]
17. Ranitidine in the prevention of gastric and duodenal ulcer relapse.
Alstead EM; Ryan FP; Holdsworth CD; Ashton MG; Moore M
Gut; 1983 May; 24(5):418-20. PubMed ID: 6301956
[TBL] [Abstract][Full Text] [Related]
18. Ulcer healing and relapse prevention by ranitidine in peptic ulcer disease.
Liedberg G; Davies HJ; Enskog L; Eriksson S; Frederiksen B; Graffner H; Hradsky M; Oscarson J; Rydberg B; Simert G
Scand J Gastroenterol; 1985 Oct; 20(8):941-4. PubMed ID: 3909374
[TBL] [Abstract][Full Text] [Related]
19. Ranitidine and duodenal ulceration: a short-term and maintenance study.
Sheers R; McKay JS; Hughes S
J R Soc Med; 1982 May; 75(5):323-6. PubMed ID: 6122738
[TBL] [Abstract][Full Text] [Related]
20. Treatment of duodenal ulcer with ranitidine, a new histamine H2-receptor antagonist.
Berstad A; Kett K; Aadland E; Carlsen E; Frislid K; Saxhaug K; Kruse-Jensen A
Scand J Gastroenterol; 1980; 15(5):637-9. PubMed ID: 6108607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
